Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

Eli Lilly · Phase 2 · Completed · Enrollment 354

NCT06326060

ArmPopulationDoseWeeksEstimandWeight change
Dosing scheme a: NNC0519-0130Obesity or overweightn/r42n/rn/r
Dosing scheme a: PlaceboObesity or overweightn/r42n/rn/r
Dosing scheme b: NNC0519-0130Obesity or overweightn/r42n/rn/r
Dosing scheme b: PlaceboObesity or overweightn/r42n/rn/r
Dosing scheme c: NNC0519-0130Obesity or overweightn/r42n/rn/r
Dosing scheme c: PlaceboObesity or overweightn/r42n/rn/r
Dosing scheme d: NNC0519-0130Obesity or overweightn/r42n/rn/r
Dosing scheme d: PlaceboObesity or overweightn/r42n/rn/r
Dosing scheme e: NNC0519-0130Obesity or overweightn/r42n/rn/r
Dosing scheme e: PlaceboObesity or overweightn/r42n/rn/r
Dosing scheme f: NNC0519-0130Obesity or overweightn/r42n/rn/r
Dosing scheme f: PlaceboObesity or overweightn/r42n/rn/r
Dosing scheme g: TirzepatideObesity or overweightn/r42n/rn/r